An ocular mucosal administration of nanoparticles containing DNA vaccine pRSC-gD-IL-21 confers protection against mucosal challenge with herpes simplex virus type 1 in mice-Reference-Cited by-同舟云学术

An ocular mucosal administration of nanoparticles containing DNA vaccine pRSC-gD-IL-21 confers protection against mucosal challenge with herpes simplex virus type 1 in mice

Published:2011-02 Issue:7 Volume:29 Page:1455-1462
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Hu Kai,Dou Jun,Yu Fangliu,He Xiangfeng,Yuan Xianwen,Wang Yaqing,Liu Chunsheng,Gu Ning

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference41 articles.

1. Modalities to decrease stromal herpes simplex keratitis reactivation rates;Sheppard;Arch Ophthalmol,2009

2. A kinetic study of gamma interferon production in herpes simplex virus-1 DNA prime-protein boost regimen comparing to DNA or subunit vaccination;Arefian;Mol Biol (Mosk),2009

3. Herpetic stromal keratitis: an immunopathologic disease mediated by CD4+ T lymphocytes;Doymaz;Invest Ophthalmol Vis Sci,1992

4. Genetic engineering of a modified herpes simplex virus 1 vaccine vector;Liu;Vaccine,2009

5. Glycoprotein-adjuvant vaccine to prevent genital herpes;Stanberry;N Engl J Med,2002

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunological Considerations for the Development of an Effective Herpes Vaccine;Microorganisms;2024-09-06

2. Understanding Mucosal Physiology and Rationale of Formulation Design for Improved Mucosal Immunity;ACS Applied Bio Materials;2024-05-24

3. An Algorithm for the Development of a Recombinant Antiherpetic Subunit Vaccine Combining the Crystal Structure Analysis, AlphaFold2-Based Modeling, and Immunoinformatics;Crystals;2023-09-24

4. Nanocarrier vaccine therapeutics for global infectious and chronic diseases;Materials Today;2023-06

5. Insights into the Novel Therapeutics and Vaccines against Herpes Simplex Virus;Vaccines;2023-01-31